It is now almost a decade since the identification of the Huntingtons Disease gene and its mutation, during which time, major advances in our understanding of this disorder have been achieved. Since publication of the first two editions of this book, there have been considerable insights into how the mutation leads to the molecular pathology, neuropathology and clinical symptoms of Huntingtons Disease, and experimental tools are now in place to take this research further towardsnew therapeutic approaches. As a result of these major advances, this well-established series of books has required radical updating. An international group of researchers and clinicians with specialist interests in HD has been commissioned to document the recent advances in our understanding of this disease. Developments in the fields of structural biology, cell biology, neurochemistry and neuropathology, with full coverage of transgenic animal models, are discussed in detail. The clinical sections cover genetic, neurological and psychiatric aspects as well as new developments in therapy. This book will continue to provide an invaluable source of information for clinicians and scientists involved with Huntingtons Disease, including geneticists, psychiatrists and neurologists, and basic science research workers in genetics and neurobiology.
Section 1 - Clinical aspects of Huntingtons disease; Huntingtons disease: a historical background; Clinical neurology of Huntingtons disease; Neuropsychological and neuropsychiatric aspects of Huntingtons disease; Imaging Huntingtons disease; Section 2 - The genetics of Huntingtons disease; Huntingtons disease: genetic and molecular studies; The epidemiology of Huntingtons disease; Genetic counselling and presymptomatic testing; Section 3 - Neurobiology; The neuropathology of Huntingtons disease; Neurochemistry of Huntingtons disease; Energy metabolism and Huntingtons disease; Section 4 - Molecular biology and Huntingtons disease; Structural biology of Huntingtons disease; The cell biology of Huntingtons disease; Mouse models of Huntingtons disease; Section 5 - Other polyglutamine diseases; The polyglutamine disease; Section 6 - Therapeutic Interventions; Comprehensive care in Huntingtons disease; Therapeutic trials in Huntingtons disease; Cell and tissue transplantation;
Komentarze (0)
Chwilowo nie możesz polubić tej opinii
Zgłoś komentarz
Czy jesteś pewien, że chcesz zgłosić ten komentarz?
Zgłoszenie wysłane
Twój komentarz został wysłany i będzie widoczny po zatwierdzeniu przez moderatora.